The Rare Cancer Research Foundation (RCRF) is a 501(c)3 dedicated to curing rare cancers through strategic investments and innovative collaborations that facilitate effective research and accelerate deployment of promising therapies.
June 02, 2023
Article
April 19, 2023
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Darzalex Regimen May Improve MRD Responses in Multiple Myeloma
How to Self Advocate When Insurance Says No to Cancer Treatment Coverage
FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset